glp-1 receptor agonists in idiopathic intracranial hypertension Treatment with is associated with significant weight loss and favorable headache outcomes | The Journal of Headache and Pain GLP-1 Receptor Agonists in Idiopathic

[DOI] [PubMed] [Google Scholar] 66.Krajnc N, Itariu B, Macher S, Marik W, Harreiter J, Michl M, et al

Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses

Sustainability Concerns : The requirement for potentially lifelong therapy, combined with rapid weight regain upon discontinuation, raises questions about long-term sustainability and practical implementation

470 In this study, researchers randomized 529 patients with heart failure with a preserved ejection fraction and body mass index (weight in kilograms in the square of the height in meters) 30 to receive once-weekly injections of semaglutide (2.4 mg) or placebo for 52 weeks

4), which did not withstand the adjustment for weight loss (Supplementary Table 2)